1. Home
  2. WIX vs AAPG Comparison

WIX vs AAPG Comparison

Compare WIX & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wix.com Ltd.

WIX

Wix.com Ltd.

HOLD

Current Price

$80.11

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

AAPG

Ascentage Pharma Group International American Depository Shares

HOLD

Current Price

$18.85

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WIX
AAPG
Founded
2006
2009
Country
Israel
China
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2013
2024

Fundamental Metrics

Financial Performance
Metric
WIX
AAPG
Price
$80.11
$18.85
Analyst Decision
Buy
Strong Buy
Analyst Count
22
5
Target Price
$134.67
$48.40
AVG Volume (30 Days)
1.5M
4.2K
Earning Date
05-13-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.80
$290.34
Revenue Next Year
$13.21
N/A
P/E Ratio
$28.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$40.00
$16.36
52 Week High
$190.92
$48.45

Technical Indicators

Market Signals
Indicator
WIX
AAPG
Relative Strength Index (RSI) 75.07 55.27
Support Level $75.00 $18.56
Resistance Level $81.44 $20.40
Average True Range (ATR) 5.11 0.42
MACD 1.75 0.15
Stochastic Oscillator 99.76 92.75

Price Performance

Historical Comparison
WIX
AAPG

About WIX Wix.com Ltd.

Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years, it has invested heavily and introduced its Wix Studio offering for partners, which are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: